Sign up for free psoriasis treatment tips by email.

EMAIL ADDRESS:


Find us on Facebook




Latest News

SEE ALLOur Sponsors




Archive for June, 2009

Institute of Medicine report urges “comparative effectiveness” research on psoriasis, but beware risk of rationing

June 30th 2009 | Biologics, Psoriasis Research, Public policy issues | 0 Comments
SHARE THIS POST
  • email
  • RSS
  • Facebook
  • Twitter
  • del.icio.us
  • LinkedIn
  • StumbleUpon

“Psoriasis Cure Now,” a nonprofit patient advocacy group, today applauded the Institute of Medicine (IOM) for including psoriasis and psoriatic arthritis among its Top 100 health topics meriting priority “comparative effectiveness” research, but the organization expressed concern that treatment rationing could result from the research.
The IOM included the use of biologics for treating inflammatory diseases
READ THE FULL POST

Psoriasis Increases Risk of Cardiovascular Disease

June 24th 2009 | Impact of psoriasis, Psoriasis Research | 0 Comments
SHARE THIS POST
  • email
  • RSS
  • Facebook
  • Twitter
  • del.icio.us
  • LinkedIn
  • StumbleUpon

A University of Miami study published in the June issue of the Archives of Dermatology concluded that psoriasis patients face an increased risk of heart attack, stroke, or death. According to Forbes.com, the 20 year study, which compared 3,235 psoriasis patients with 2,500 patients without the disease, found a “78 percent higher incidence of
READ THE FULL POST

At-Home UVB Treatment for Psoriasis is as Safe as Hospital Treatment, Study Finds

June 9th 2009 | Psoriasis Research, Treatment | 0 Comments
SHARE THIS POST
  • email
  • RSS
  • Facebook
  • Twitter
  • del.icio.us
  • LinkedIn
  • StumbleUpon

A Dutch study published in the British Medical Journal (BMJ) concluded that home-based ultraviolet B (UVB) treatment for psoriasis is as effective and safe as outpatient treatment typically conducted in a physician’s office or dermatology clinic.
Traditional UVB treatment for psoriasis can be time-consuming, often requiring three trips per week, for several months, to a doctor’s
READ THE FULL POST

Obesity May Increase Risk of Psoriatic Arthritis

June 5th 2009 | Psoriasis Research, Triggers/environment | 0 Comments
SHARE THIS POST
  • email
  • RSS
  • Facebook
  • Twitter
  • del.icio.us
  • LinkedIn
  • StumbleUpon

According to an abstract presented at the Society for Investigative Dermatology’s annual meeting, obese psoriasis patients face a greater risk of developing psoriatic arthritis. Researchers at the Utah Psoriasis Initiative found that a one-unit increase in body mass index (BMI) increased the risk of psoriatic arthritis by 5.4%. BMI is a measure of body
READ THE FULL POST

June psoriasis informational meetings

June 4th 2009 | Misc. | 2 Comments
SHARE THIS POST
  • email
  • RSS
  • Facebook
  • Twitter
  • del.icio.us
  • LinkedIn
  • StumbleUpon

The company Abbott (which markets the psoriasis and psoriatic arthritis treatment Humira) is hosting informational meetings about psoriasis and its treatments in five cities during June 2009, as follows:
June 13, Baton Rouge, LA
June 16, Grand Rapids, MI
June 18, Jacksonville, FL
June 25, Syracuse, NY
June 27, Richmond, VA
For more information or to register, call Abbott at 1-866-598-9536
READ THE FULL POST

Psoriasis Walks

June 2nd 2009 | Psoriasis Walk | 0 Comments
SHARE THIS POST
  • email
  • RSS
  • Facebook
  • Twitter
  • del.icio.us
  • LinkedIn
  • StumbleUpon

Psoriasis Walks. Philadelphia, North Jersey, Baltimore, Charlotte, Phoenix. Summer and Fall 2009. Registration live! http://www.PsoriasisWalk.org

June psoriasis calendar profile is live

June 2nd 2009 | Patient Stories | 0 Comments
SHARE THIS POST
  • email
  • RSS
  • Facebook
  • Twitter
  • del.icio.us
  • LinkedIn
  • StumbleUpon

Check out our June Psoriasis Calendar profile of Jason, a law student who recounts life with, then without, then again with his preferred treatment. Many psoriasis patients will relate completely with his story.

© 2005-2012 Psoriasis Cure Now WEB DESIGN BY SKYHOOK MARKETING